What does Novadip Biosciences do?
NOVADIP BIOSCIENCES is a biotechnology company specializing in regenerative medicine. It focuses on developing innovative treatments for musculoskeletal disorders using its proprietary adipose-derived stem cell technology. The company aims to improve patient outcomes through advanced cellular therapies.
- Signals
-
Reporting lossesReporting losses € -13.14M
The company reported a loss in the latest financial year.
Poor liquidityPoor liquidity 0.95The current ratio is below 1: may be insufficient to cover short-term debt.
Negative EBITDANegative EBITDA € -1.95MEBITDA is negative: operating activities are loss-making.
Strong equityStrong equity € 49.98MStrong equity provides a buffer against setbacks.
Low riskLow risk 58.6%Good solvency (> 30%) points to long-term financial stability.
Positive cashflowPositive cashflow € 4.46MPositive operating cash flow in the latest financial year.
Healthy social debtHealthy social debt 19.6%Social debts stay manageable relative to personnel costs.
Financial ratios
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
€
1.63M
|
€
2.21M
|
|
|
|
|
€
-1.95M
|
€
-2.47M
|
€
-2.10M
|
€
-1.87M
|
|
|
€
-13.14M
|
€
-2.63M
|
€
-1.94M
|
€
-2.31M
|
|
|
€
49.98M
|
€
66.57M
|
€
66.18M
|
€
65.08M
|
|
|
58.61%
|
72.72%
|
82.46%
|
89.55%
|
|
|
€
35.30M
|
€
24.98M
|
€
14.04M
|
€
7.56M
|
|
|
€
7.18M
|
€
6.06M
|
€
8.77M
|
€
15.37M
|
|
|
41.00
|
40.70
|
42.70
|
36.20
|
Publications 27
All publications- Divers 09/01/2024
- Statuts (Traduction, Coordination, Autres Modifications, ) - Capital, Actions 04/08/2023
- Demissions, Nominations 28/11/2022
- Capital, Actions 10/10/2022
- Statuts (Traduction, Coordination, Autres Modifications, ) - Capital, Actions 24/05/2022
News
Show all- Novadip Biosciences’ Osteobiologic Platform: Autologous Limb-Saving Bone Regeneration And Allogeneic Bioactive Powder For Trauma And Spine Fusion By 2027 Dealroom 5 months ago
- Novadip’s Ex Vivo Stem-Cell Bone Regeneration: Turning Patient Fat Into Limb-Saving Grafts Dealroom 5 months ago
- Novadip Recruits First Pediatric Patients In Pivotal Phase 3 Trial Of Tissue Regenerative Treatment Nvd003 In Congenital Pseudoarthrosis Of The Tibia Menafn 9 months ago
- Mytos Advances Automated Ipsc Manufacturing Through Strategic Partnerships With Stemsight, Rinri Therapeutics, And Novadip BioInformant 1 year ago
- Mytos Announces Strategic Partnerships With Stemsight, Rinri Therapeutics, And Novadip To Power Next-Generation Cell Therapy Trials Business Wire 1 year ago
Frequently asked questions
Answers to the most common questions about Novadip Biosciences, based on official government data and the filed annual accounts.
What is the VAT number of Novadip Biosciences?
The VAT number of Novadip Biosciences is BE0535.575.602.
How many employees work at Novadip Biosciences?
In 2025, Novadip Biosciences employed 41.00 full-time equivalents (FTE).
When was Novadip Biosciences established?
Novadip Biosciences was founded in 31-05-2013.
What is the official address of Novadip Biosciences?
The official address of Novadip Biosciences is Rue Granbonpré 11 Mont-Saint-Guibert 1435.
What is the legal form of Novadip Biosciences?
The juridical form of Novadip Biosciences is Public limited company (NV/SA).
What is the annual revenue of Novadip Biosciences?
The 2025 accounts of Novadip Biosciences do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Novadip Biosciences do?
NOVADIP BIOSCIENCES is a biotechnology company specializing in regenerative medicine. It focuses on developing innovative treatments for musculoskeletal disorders using its proprietary adipose-derived stem cell technology. The company aims to improve patient outcomes through advanced cellular therapies.
Is Novadip Biosciences a reliable company?
Novadip Biosciences is a registered Rechtspersoon with company number 0535.575.602 and can be verified through the official CBE database.
What is the credit limit of Novadip Biosciences?
The estimated credit limit of Novadip Biosciences is €2,136,476.
Is Novadip Biosciences still active?
Novadip Biosciences currently has the status "Normal situation" and is active.